Prot# N49-02-12-202: REVISED Protocol for a Double-Blind, Placebo-Controlled, Randomized Comparison of the Efficacy and Safety of Celecoxib 200mg and Celecoxib 400mg QD in Treating the Signs and Symptoms of Psoriatic Arthritis